Piramal Pharma s’est engagé à réduire ses émissions de GES pour les champs d’application 1, 2 et 3 d’ici 2030 BOMBAY, Inde, 17 septembre 2024 /PRNewswire/ — Piramal Pharma Limited (NSE : PPLPHARMA) (BSE : 543635), l’une des principales entreprises pharmaceutiques mondiales, s’est engagé…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.